Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Ahva R. Mozafari, Alina Bonci Shaw & Shannon M. Lynch. (2023) The Influence of Interpersonal Violence and Adult Attachment on Incarcerated Women’s Mental Health and Parenting Self-Perception. Journal of Aggression, Maltreatment & Trauma 0:0, pages 1-20.
Read now
Read now
Tomiki Sumiyoshi, Hiroyuki Uchida, Koichiro Watanabe, Masato Oosawa, Hongye Ren, Yoshiya Moriguchi, Keita Fujikawa & Jovelle Fernandez. (2022) Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder. Neuropsychiatric Disease and Treatment 18, pages 2507-2517.
Read now
Read now
Bernhard T Baune, Ioana Florea, Bjarke Ebert, Maëlys Touya, Anders Ettrup, Monica Hadi & Hongye Ren. (2021) Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study. Neuropsychiatric Disease and Treatment 17, pages 2995-3006.
Read now
Read now
Tomiki Sumiyoshi, Koichiro Watanabe, Shinichi Noto, Shigeru Sakamoto, Yoshiya Moriguchi, Lene Hammer-Helmich & Jovelle Fernandez. (2021) Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J. Neuropsychiatric Disease and Treatment 17, pages 945-955.
Read now
Read now
Guy Potter, Daniel Hatch, Hannah Hagy, Thea Radüntz, Patrick Gajewski, Michael Falkenstein & Gabriele Freude. (2021) Slower information processing speed is associated with persistent burnout symptoms but not depression symptoms in nursing workers. Journal of Clinical and Experimental Neuropsychology 43:1, pages 33-45.
Read now
Read now
Gang Wang, Kristin Hui Xian Tan, Hongye Ren & Lene Hammer-Helmich. (2020) Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study. Neuropsychiatric Disease and Treatment 16, pages 749-759.
Read now
Read now
Rajeev Ayyagari, Darren Thomason, Fan Mu, Michael Philbin & Benjamin Carroll. (2020) Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disorders. Journal of Medical Economics 23:2, pages 204-212.
Read now
Read now
William Jacobson, Wei Zhong, George G. Nomikos, Michael Cronquist Christensen, Christina Kurre Olsen & Philip D. Harvey. (2020) Effects of vortioxetine on functional capacity across different levels of functional impairment in patients with major depressive disorder: a University of California, San Diego Performance-based Skills Assessment (UPSA) analysis. Current Medical Research and Opinion 36:1, pages 117-124.
Read now
Read now
Hikaru Hori & Kentaro Yamato. (2019) Assessment of current clinical practices for major depression in Japan using a web-based questionnaire. Neuropsychiatric Disease and Treatment 15, pages 2821-2832.
Read now
Read now
Josep Maria Haro, Lene Hammer-Helmich, Delphine Saragoussi, Anders Ettrup & Klaus Groes Larsen. (2019) Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study. Neuropsychiatric Disease and Treatment 15, pages 2313-2323.
Read now
Read now
Gang Wang, Tian-Mei Si, Lingjiang Li, Yiru Fang, Chun-Xue Wang, Li-Na Wang, Kristin Hui Xian Tan, Anders Ettrup, Hanne-Lise Falgreen Eriksen, Si Luo & Lan Ge. (2019) Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China. Neuropsychiatric Disease and Treatment 15, pages 1723-1736.
Read now
Read now
Delphine Saragoussi, Michael Cronquist Christensen, Lene Hammer-Helmich, Benoît Rive, Maëlys Touya & Josep Maria Haro. (2018) Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study. Neuropsychiatric Disease and Treatment 14, pages 1339-1350.
Read now
Read now
Articles from other publishers (47)
N. V. Stoyan, O. M. Ocheredko, V. O. Korobchanskyi, O. Yu. Bratkova & O. A. Serebrennikova. (2023) Adaptive capabilities of the body and aggressive personality manifestations of modern students at various stages of education in a higher education institution. Reports of Morphology 29:1, pages 24-33.
Crossref
Crossref
Susana S Almeida, Michael Cronquist Christensen, Kenneth Simonsen & Michael Adair. (2022) Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study. Journal of Psychopharmacology 37:3, pages 279-288.
Crossref
Crossref
A. De la Rosa-Cáceres, O. M. Lozano, M. Sanchez-Garcia, F. Fernandez-Calderon, G. Rossi & C. Diaz-Batanero. (2023) Assessing Internalizing Symptoms and Their Relation with Levels of Impairment: Evidence-Based Cutoffs for Interpreting Inventory of Depression and Anxiety Symptoms (IDAS-II) Scores. Journal of Psychopathology and Behavioral Assessment 45:1, pages 170-180.
Crossref
Crossref
D.A. van Dijk, R.M. Meijer, Th.M. van den Boogaard, J. Spijker, H.G. Ruhé & F.P.M.L. Peeters. (2023) Worse off by waiting for treatment? The impact of waiting time on clinical course and treatment outcome for depression in routine care. Journal of Affective Disorders 322, pages 205-211.
Crossref
Crossref
Gregory Mattingly, Elizabeth Brunner, Lambros Chrones, Debra F. Lawrence, Kenneth Simonsen & Hongye Ren. (2023) Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study. Frontiers in Psychiatry 13.
Crossref
Crossref
Koichiro Watanabe, Tatsuro Marumoto, Holly Ge, Yoshiya Moriguchi, Keita Fujikawa & Jovelle L. Fernandez. (2022) Association between baseline cognitive symptoms and the subsequent presenteeism and global function in patients with major depressive disorder. Journal of Psychiatric Research 154, pages 324-331.
Crossref
Crossref
E. Papalexi, A. Galanopoulos, D. Roukas, I. Argyropoulos, I. Michopoulos, A. Douzenis, I. Gkolia, P. Fotiadis, D. Kontis & I.M. Zervas. (2022) Residual cognitive and psychosocial functional impairment in outpatients in Greece who responded to conventional antidepressant monotherapy treatments for major depressive disorder (MDD). Journal of Affective Disorders 314, pages 185-192.
Crossref
Crossref
Eugenia Papalexi, Andreas Galanopoulos, Dimitrios Kontis, Maria Markopoulou, Georgia Balta, Evaggelos Karavelas, Panagiotis Panagiotidis, Themistoklis Vlachos & Anders Ettrup. (2022) Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects. BMC Psychiatry 22:1.
Crossref
Crossref
Tobias Hecker, Edna Kyaruzi, Julia Borchardt & Florian Scharpf. (2021) Factors Contributing to Violence Against Children: Insights From a Multi-informant Study Among Family-Triads From Three East-African Refugee Camps. Journal of Interpersonal Violence 37:15-16, pages NP14507-NP14537.
Crossref
Crossref
Juliana de Almeida Prado & Jair Lício Ferreira Santos. (2021) Psychosocial functionality in depressive workers: A study on associated factors. International Journal of Social Psychiatry 68:5, pages 958-968.
Crossref
Crossref
Wen-Wang Rao, Muzi Li, Yingying Su, Jean Caron, Yu-Tao Xiang & Xiangfei Meng. (2022) How psychosocial stress profile influences the subsequent occurrence of neuropsychiatric comorbidities: A longitudinal population-based cohort study. Journal of Affective Disorders 311, pages 294-302.
Crossref
Crossref
Paola Bozzatello, Benedetta Giordano, Cristiana Montemagni, Paola Rocca & Silvio Bellino. (2022) Real-World Functioning in Psychiatric Outpatients: Predictive Factors. Journal of Clinical Medicine 11:15, pages 4400.
Crossref
Crossref
Sara Barrio-Martínez, César González-Blanch, Amador Priede, Roger Muñoz-Navarro, Leonardo Adrián Medrano, Juan Antonio Moriana, María Carpallo-González, Ludovica Ventura, Paloma Ruiz-Rodríguez & Antonio Cano-Vindel. (2022) Emotion Regulation as a Moderator of Outcomes of Transdiagnostic Group Cognitive-Behavioral Therapy for Emotional Disorders. Behavior Therapy 53:4, pages 628-641.
Crossref
Crossref
Jose C. Appolinario, Rosely Sichieri, Claudia S. Lopes, Carlos E. Moraes, Gloria V. da Veiga, Silvia Freitas, Maria A. A. Nunes, Yuan-Pang Wang & Phillipa Hay. (2022) Correlates and impact of DSM-5 binge eating disorder, bulimia nervosa and recurrent binge eating: a representative population survey in a middle-income country. Social Psychiatry and Psychiatric Epidemiology 57:7, pages 1491-1503.
Crossref
Crossref
Josée M. Dussault, Chifundo Zimba, Jullita Malava, Harriet Akello, Melissa A. Stockton, Michael Udedi, Bradley N. Gaynes, Mina C. Hosseinipour, Brian W. Pence & Jones Masiye. (2021) “Thandi should feel embarrassed”: describing the validity and reliability of a tool to measure depression-related stigma among patients with depressive symptoms in Malawi. Social Psychiatry and Psychiatric Epidemiology 57:6, pages 1211-1220.
Crossref
Crossref
Joanna Tomczyk, John B. Nezlek & Izabela Krejtz. (2022) Gratitude Can Help Women At-Risk for Depression Accept Their Depressive Symptoms, Which Leads to Improved Mental Health. Frontiers in Psychology 13.
Crossref
Crossref
Sara de la Salle, Jennifer L. Phillips, Pierre Blier & Verner Knott. (2022) Electrophysiological correlates and predictors of the antidepressant response to repeated ketamine infusions in treatment-resistant depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 115, pages 110507.
Crossref
Crossref
American Psychiatric Association. 2022. Diagnostic and Statistical Manual of Mental Disorders. Diagnostic and Statistical Manual of Mental Disorders.
Gregory W. Mattingly, Hongye Ren, Michael Cronquist Christensen, Martin A. Katzman, Mircea Polosan, Kenneth Simonsen & Lene Hammer-Helmich. (2022) Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study. Frontiers in Psychiatry 13.
Crossref
Crossref
Ji Hyun Baek. (2022) Cognition in Depression. Psychiatric Annals 52:3, pages 91-92.
Crossref
Crossref
James Altunkaya, Jung-Seok Lee, Apostolos Tsiachristas, Felicity Waite, Daniel Freeman & José Leal. (2021) Appraisal of patient-level health economic models of severe mental illness: systematic review. The British Journal of Psychiatry 220:2, pages 86-97.
Crossref
Crossref
Bruna Gomes Mônego, Rochele Paz Fonseca, Antônio Lúcio Teixeira, Izabela Guimarães Barbosa, Leonardo Cruz de Souza & Denise Ruschel Bandeira. (2022) Transtorno Depressivo Maior: Um Estudo Comparativo sobre Cognição Socioemocional e Funções Executivas. Psicologia: Teoria e Pesquisa 38.
Crossref
Crossref
Victor W. Li, Emma Morton, Erin E. Michalak, Edwin M. Tam, Anthony J. Levitt, Robert D. Levitan, Amy Cheung, Rachel Morehouse, Rajamannar Ramasubbu, Lakshmi N. Yatham & Raymond W. Lam. (2022) Functional outcomes with bright light in monotherapy and combined with fluoxetine in patients with major depressive disorder: Results from the LIFE-D trial. Journal of Affective Disorders 297, pages 396-400.
Crossref
Crossref
Tomiki Sumiyoshi, Tatsuya Hoshino, Izumi Mishiro, Lene Hammer-Helmich, Holly Ge, Yoshiya Moriguchi, Keita Fujikawa & Jovelle L. Fernandez. (2022) Prediction of residual cognitive disturbances by early response of depressive symptoms to antidepressant treatments in patients with major depressive disorder. Journal of Affective Disorders 296, pages 95-102.
Crossref
Crossref
Elisa Borroni, Angela Cecilia Pesatori, Valentina Bollati, Massimiliano Buoli & Michele Carugno. (2022) Air pollution exposure and depression: A comprehensive updated systematic review and meta-analysis. Environmental Pollution 292, pages 118245.
Crossref
Crossref
Erika M. Salarda, Belinda U. Busogi & Gabriel R. Fries. 2022. Epigenetics of Stress and Stress Disorders. Epigenetics of Stress and Stress Disorders
207
224
.
Han Han, Yanyan Hou, Shuqiao Yao, Shaohua Hu, Qi Zhou, Xin Yu, Roger S. McIntyre & Chuan Shi. (2021) The Relationship Between Cognitive Dysfunction Through THINC-Integrated Tool (THINC-it) and Psychosocial Function in Chinese Patients With Major Depressive Disorder. Frontiers in Psychiatry 12.
Crossref
Crossref
Jialing Zhang, Jiping Zhang, Zhinan Zhang, Yu Zheng, Zheng Zhong, Zengyu Yao, Xiaowen Cai, Lixing Lao, Yong Huang & Shanshan Qu. (2021)
Dopaminergic signaling in prefrontal cortex contributes to the antidepressant effect of electroacupuncture: An
iTRAQ‐based
proteomics analysis in a rat model of
CUMS
. The Anatomical Record 304:11, pages 2454-2469.
Crossref
Crossref
Kenneth Sandin, Gemma E. Shields, Ragne G. H. Gjengedal, Kåre Osnes, Marianne Tranberg Bjørndal & Odin Hjemdal. (2021) Self-Reported Health in Patients on or at Risk of Sick Leave Due to Depression and Anxiety: Validity of the EQ-5D. Frontiers in Psychology 12.
Crossref
Crossref
Dipal Nagda, William Mitchell & Nazlee Zebardast. (2021) The functional burden of diabetic retinopathy in the United States. Graefe's Archive for Clinical and Experimental Ophthalmology 259:10, pages 2977-2986.
Crossref
Crossref
Hannah N. Ziobrowski, Lucinda B. Leung, Robert M. Bossarte, Corey Bryant, Janelle N. Keusch, Howard Liu, Victor Puac-Polanco, Wilfred R. Pigeon, David W. Oslin, Edward P. Post, Alan M. Zaslavsky, Jose R. Zubizarreta & Ronald C. Kessler. (2021) Comorbid mental disorders, depression symptom severity, and role impairment among Veterans initiating depression treatment through the Veterans Health Administration. Journal of Affective Disorders 290, pages 227-236.
Crossref
Crossref
Nelson B. Rodrigues, Roger S. McIntyre, Orly Lipsitz, Yena Lee, Mehala Subramaniapillai, Kevin Kratiuk, Amna Majeed, Flora Nasri, Hartej Gill, Rodrigo B. Mansur & Joshua D. Rosenblat. (2021) The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellence. Psychiatry Research 300, pages 113860.
Crossref
Crossref
Cheolmin Shin, Chi-Un Pae, Kyung Phil Kwak, Sang Won Jeon, Hyun-Ghang Jeong, Jong-Woo Kim, Youn Jung Lee, Ashwin A. Patkar & Changsu Han. (2021) Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder. Clinical Psychopharmacology and Neuroscience 19:2, pages 243-253.
Crossref
Crossref
Bing Cao, Lu Xu, Yan Chen, Dongfang Wang, Yena Lee, Joshua D. Rosenblat, Xiao Gao, Siyan Zhan, Feng Sun & Roger S. McIntyre. (2021) Comparative efficacy of pharmacological treatments on measures of self-rated functional outcomes using the Sheehan Disability Scale in patients with major depressive disorder: a systematic review and network meta-analysis. CNS Spectrums, pages 1-9.
Crossref
Crossref
Neha Sahasrabudhe, Jong Soo Lee, Tammy M Scott, Laura Punnett, Katherine L Tucker & Natalia Palacios. (2020) Serum Vitamin D and Depressive Symptomatology among Boston-Area Puerto Ricans. The Journal of Nutrition 150:12, pages 3231-3240.
Crossref
Crossref
Michael Cronquist Christensen, Chiew Meng Johnny Wong & Bernhard T. Baune. (2020) Symptoms of Major Depressive Disorder and Their Impact on Psychosocial Functioning in the Different Phases of the Disease: Do the Perspectives of Patients and Healthcare Providers Differ?. Frontiers in Psychiatry 11.
Crossref
Crossref
Pratap Chokka, Anders Holmegaard Tvistholm, Joanna Bougie, Guerline Clerzius & Anders Ettrup. (2020) Improvements in Workplace Productivity in Working Patients With Major Depressive Disorder. Journal of Occupational & Environmental Medicine 62:3, pages e94-e101.
Crossref
Crossref
Dena H. Jaffe, Benoit Rive & Tom R. Denee. (2019) The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study. BMC Psychiatry 19:1.
Crossref
Crossref
Pratap Chokka, Joanna Bougie, Jean Proulx, Anders Holmegaard Tvistholm & Anders Ettrup. (2019) Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study. CNS Spectrums 24:6, pages 616-627.
Crossref
Crossref
Tomiki Sumiyoshi, Koichiro Watanabe, Shinichi Noto, Shigeru Sakamoto, Yoshiya Moriguchi, Kristin Hui Xian Tan, Lene Hammer-Helmich & Jovelle Fernandez. (2019) Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross–sectional analysis of baseline data from PERFORM-J. Journal of Affective Disorders 258, pages 172-178.
Crossref
Crossref
Sanne Wassink-Vossen, Rose M. Collard, Klaas J. Wardenaar, Peter F.M. Verhaak, Didi Rhebergen, Paul Naarding & Richard C. Oude Voshaar. (2020) Trajectories and determinants of functional limitations in late-life
depression: A 2-year prospective cohort study. European Psychiatry 62, pages 90-96.
Crossref
Crossref
Charlie N. Knowlton, Alena Kryvanos, Megan Poole, Michael Christopher & Theresa Lafavor. (2019) Acceptance and Commitment Therapy for the Treatment of Chronic Pain and Coexisting Depression: A Single-Case Study. Clinical Case Studies 18:4, pages 254-269.
Crossref
Crossref
Oleg A. Levada & Alexandra S. Troyan. (2019) Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram. Journal of Affective Disorders 250, pages 114-122.
Crossref
Crossref
Nor Zuraida Zainal, Pranab Kalita & Keira Joann Herr. (2018) Cognitive dysfunction in Malaysian patients with major depressive disorder: A subgroup analysis of a multicountry, cross‐sectional study. Asia-Pacific Psychiatry 11:1, pages e12346.
Crossref
Crossref
Amjed Abu-Ghname, Michelle Clementi, StephanieA Marton, Heidi Schwarzwald, Erica Giwa, Lisa Hollier & StephanieG Chapman. (2019) Behavioral health service utilization: Trends in utilization within a patient-centered medical home for low-income children and women. Journal of Family Medicine and Primary Care 8:12, pages 3983.
Crossref
Crossref
Eun-Hee Park & Myung Hun Jung. (2019) The impact of major depressive disorder on adaptive function. Medicine 98:52, pages e18515.
Crossref
Crossref
Tomiki Sumiyoshi, Koichiro Watanabe, Shinichi Noto, Shigeru Sakamoto, Yoshiya Moriguchi & Shuichi Okamoto. (2018) Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder in Japan (PERFORM-J): Protocol for a Prospective Cohort Study. JMIR Research Protocols 7:6, pages e161.
Crossref
Crossref